The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

Physical activity levels have a significant association with a reduced incidence of restrictive spirometry patterns (RSP).

Metformin was associated with significantly reduced knee pain among patients with overweight/obesity and knee osteoarthritis.

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

The global age-standardized incidence and prevalence rates of RA increased from 1990 to 2021 while mortality rates declined.

Neuraxial anesthesia is associated with significantly reduced odds of several major postoperative complications in patients undergoing hip fracture procedures, according to resear ...

Male athletes with high-volume exercise training have a higher burden of calcified plaque than male nonathletes.

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.